MEI Pharma (MEIP)
(Delayed Data from NSDQ)
$3.26 USD
-0.07 (-2.17%)
Updated Apr 24, 2024 03:54 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for MEI Pharma, Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -31.84 | -54.45 | -50.58 | -46.02 | -16.82 |
Depreciation/Amortization & Depletion | 0.39 | 0.33 | 0.29 | 0.34 | 0.08 |
Net Change from Assets/Liabilities | -24.95 | 16.88 | 26.20 | 50.27 | 8.39 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.92 | -11.49 | -7.88 | 29.67 | -21.07 |
Net Cash From Operating Activities | -52.48 | -48.75 | -31.96 | 34.26 | -29.42 |
Property & Equipment | -0.04 | -0.48 | -0.71 | -0.89 | -0.22 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 53.73 | 7.37 | 25.42 | -105.40 | 24.54 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 53.69 | 6.89 | 24.71 | -106.29 | 24.32 |
Uses of Funds
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 52.90 | 3.47 | 74.78 | 1.71 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.04 | -3.85 | 0.00 | 0.00 | -0.32 |
Net Cash from Financing Activities | -0.04 | 49.05 | 3.47 | 74.78 | 1.39 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 1.17 | 7.20 | -3.79 | 2.74 | -3.72 |
Cash at Beginning of Period | 15.74 | 8.54 | 12.33 | 9.59 | 13.31 |
Cash at End of Period | 16.91 | 15.74 | 8.54 | 12.33 | 9.59 |
Diluted Net EPS | -4.78 | -10.00 | -13.60 | -10.20 | -15.00 |
Fiscal Year End for MEI Pharma, Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 45.31 | 56.37 | -31.84 | -21.81 |
Depreciation/Amortization & Depletion | NA | 0.17 | 0.09 | 0.39 | 0.29 |
Net Change from Assets/Liabilities | NA | -76.99 | -75.69 | -24.95 | -22.91 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.96 | 0.74 | 3.92 | 3.25 |
Net Cash From Operating Activities | NA | -29.55 | -18.49 | -52.48 | -41.18 |
Property & Equipment | NA | -0.01 | 0.00 | -0.04 | 0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 29.48 | 4.96 | 53.73 | 34.29 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 29.47 | 4.96 | 53.69 | 34.29 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -11.66 | 0.00 | -0.04 | -0.04 |
Net Cash from Financing Activities | NA | -11.66 | 0.00 | -0.04 | -0.04 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -11.73 | -13.53 | 1.17 | -6.93 |
Cash at Beginning of Period | NA | 16.91 | 16.91 | 15.74 | 15.74 |
Cash at End of Period | NA | 5.17 | 3.37 | 16.91 | 8.81 |
Diluted Net EPS | NA | -1.66 | 8.46 | -1.66 | -2.32 |